Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Feb 1, 2012
Valuentum's February Edition of its Dividend Growth Newsletter!
The February edition of our Dividend Growth Newsletter is now available. Jan 27, 2012
Best-Idea Ford Hits Profit Snag in Fourth Quarter; 2012 Pre-Tax Operating Profit to Hold Flat
Best-idea Ford showed strong revenue performance but weak underlying profitability in its fourth-quarter results. We view the automaker as a long-term holding in the portfolio of our Best Ideas Newsletter and expect ongoing improvement from the company in the years ahead. Jan 27, 2012
Starbucks is Firing on All Cylinders But Shares Are Expensive
Starbucks put up record fiscal first-quarter results for both revenue and earnings. Though we like the coffee giant's future potential opportunities, its shares are rich at present levels. Jan 26, 2012
Caterpillar Posts Strong Fourth-Quarter Results; Sees Global Economic Acceleration in 2012
Caterpillar posted excellent fourth-quarter results and guided to a 2012 that was much better than investors were expecting. We continue to believe that the global economic environment remains conducive to expansion. Caterpillar now looks fairly valued after converging to our fair value estimate. Jan 24, 2012
Harley-Davidson Swings to Fourth-Quarter Profit; Sees More Motorcycle Sales in 2012
Harley-Davidson posted solid fourth-quarter results and pointed to a strong 2012 as it relates to motorcycle shipments. Jan 22, 2012
GE's Industrial Backlog Hits New Highs in Fourth Quarter; GE Capital Continues to Improve
General Electric reported solid fourth-quarter results that displayed a record infrastructure backlog and improving performance at GE Capital. We're growing more constructive on the industrial conglomerate's shares. Jan 19, 2012
Best-Idea eBay Reports Fantastic Fourth-Quarter Results; Outlook Tempered, as Expected
Global e-commerce giant eBay reported fantastic fourth-quarter results that showed impressive growth in its online payment processor, PayPal. We'll be looking to add to our position in eBay in the portfolio of our Best Ideas Newsletter. Jan 16, 2012
Valuentum's January Edition of Its Best Ideas Newsletter!
The January edition of our Best Ideas Newsletter is now available. Jan 13, 2012
JP Morgan Posts Fourth-Quarter Results; Sees Improving Loan Demand and Credit Quality
The largest US bank, by assets, posted fourth-quarter results. Though profit faced pressure due to declining investment-banking business, underlying trends with respect to JP Morgan's loan growth and credit quality were very encouraging. The bank continues to have a fortress balance sheet.
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657585960616263646566676869707172737475 767778798081828384858687888990919293949596979899100 101102103104105106107108109110111112113114115116117118119120 121122123124125126127128129130131132133134135136137138139140 141142143144145146147148149150151152153154155156157158159160 161162163164165166167168169170171172173174175176177178179180 181182183184185186187188189190191192193194195196197198199200 201202next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|
Gilead Sciences reported fourth-quarter results and released favorable hepatitus C data for its all-oral regimen to treat the virus, and the shares are rallying nearly 10% on the promising news. The firm has now converged to our $54 per share fair value estimate.